215 related articles for article (PubMed ID: 28440745)
1. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
[TBL] [Abstract][Full Text] [Related]
2. Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin.
Mello AGNC; Vieira MVDF; Sena LWP; Paixão TPD; Pinto ACG; Grisólia DPA; Silva MT; Vieira JLF
Rev Inst Med Trop Sao Paulo; 2018 Oct; 60():e66. PubMed ID: 30379233
[TBL] [Abstract][Full Text] [Related]
3. The extent of chloroquine underdosing in adult patients with malaria by Plasmodium vivax from an endemic area of the Brazilian Amazon basin.
Valéria Dias Ferreira M; Gabryelle Nunes Cardoso Mello A; Sena LWP; Regina Matos Lopes T; Luiz Fernandes Vieira J
Trop Med Int Health; 2020 Sep; 25(9):1093-1097. PubMed ID: 32633099
[TBL] [Abstract][Full Text] [Related]
4. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine-Primaquine Therapeutic Efficacy, Safety, and Plasma Levels in Patients with Uncomplicated
Mesa-Echeverry E; Niebles-Bolívar M; Tobón-Castaño A
Am J Trop Med Hyg; 2019 Jan; 100(1):72-77. PubMed ID: 30457097
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
9. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
10. Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors.
Gomes Mdo S; Vieira JL; Machado RL; Nacher M; Stefani A; Musset L; Legrand E; Menezes RA; Júnior AA; Sousa AP; Couto VS; Couto ÁA
Malar J; 2015 Oct; 14():402. PubMed ID: 26453152
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
[TBL] [Abstract][Full Text] [Related]
12. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
13. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.
Tasanor O; Ruengweerayut R; Sirichaisinthop J; Congpuong K; Wernsdorfer WH; Na-Bangchang K
Trans R Soc Trop Med Hyg; 2006 May; 100(5):410-8. PubMed ID: 16497347
[TBL] [Abstract][Full Text] [Related]
14. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH
Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM
Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
Chu CS; Watson JA; Phyo AP; Win HH; Yotyingaphiram W; Thinraow S; Soe NL; Aung AA; Wilaisrisak P; Kraft K; Imwong M; Hanpithakpong W; Blessborn D; Tarning J; Proux S; Ling C; Nosten FH; White NJ
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0130221. PubMed ID: 34398667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
